Cargando…

Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage

The mechanism of nigral dopaminergic neuronal degeneration in Parkinson’s disease (PD) is unknown. One of the pathological characteristics of the disease is the deposition of α-synuclein (α-syn) that occurs in the brain from both familial and sporadic PD patients. This paper constitutes a narrative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, Rafael, Rivas-Santisteban, Rafael, Navarro, Gemma, Pinna, Annalisa, Reyes-Resina, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124903/ https://www.ncbi.nlm.nih.gov/pubmed/33924963 http://dx.doi.org/10.3390/ijms22094643

Ejemplares similares

Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
por: Franco, Rafael, et al.
Publicado: (2021)

The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions
por: Franco, Rafael, et al.
Publicado: (2021)

Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells
por: Franco, Rafael, et al.
Publicado: (2021)

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons
por: Franco, Rafael, et al.
Publicado: (2023)

Angiotensin AT(1) and AT(2) receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2020)

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters
por: Franco, Rafael, et al.
Publicado: (2021)

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
por: Valenzuela, Rita, et al.
Publicado: (2021)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Discovery of nigral dopaminergic neurogenesis in adult mice
por: Morrison, Brad E.
Publicado: (2016)

Adenosine A(2A) Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
por: Franco, Rafael, et al.
Publicado: (2020)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A(2A) receptor
por: Navarro, Gemma, et al.
Publicado: (2020)

Antagonization of OX(1) Receptor Potentiates CB(2) Receptor Function in Microglia from APP(Sw/Ind) Mice Model
por: Raïch, Iu, et al.
Publicado: (2022)

Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration
por: Ayton, Scott, et al.
Publicado: (2014)

Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease
por: Chalazonitis, Alcmène, et al.
Publicado: (2022)

The Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice
por: Dong, Qiaoyun, et al.
Publicado: (2015)

Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
por: Liu, Zhenhua, et al.
Publicado: (2022)

Dopamine in Health and Disease: Much More Than a Neurotransmitter
por: Franco, Rafael, et al.
Publicado: (2021)

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease
por: García-Domínguez, Irene, et al.
Publicado: (2018)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons
por: Garrido, Manuel, et al.
Publicado: (2010)

Application of flavonoids for the protection of nigral dopaminergic neurons from oxidative stress
por: Kim, Sang Ryong
Publicado: (2020)

Height and nigral neuron density in Parkinson’s disease
por: Saari, Laura, et al.
Publicado: (2022)

Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit
por: Langley, Jason, et al.
Publicado: (2022)

Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2021)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
por: Song, Dae-Yong, et al.
Publicado: (2013)

Glutamatergic synaptic currents of nigral dopaminergic neurons follow a postnatal developmental sequence
por: Pearlstein, Edouard, et al.
Publicado: (2015)

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo
por: Leem, Eunju, et al.
Publicado: (2018)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
por: Fabricius, Katrine, et al.
Publicado: (2017)

Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
por: Wang, Tzu-Feng, et al.
Publicado: (2022)

Reward expectation enhances action-related activity of nigral dopaminergic and two striatal output pathways
por: Rios, Alain, et al.
Publicado: (2023)

Adenosine A(2A) and A(3) Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling
por: Lillo, Alejandro, et al.
Publicado: (2020)

Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson’s Disease
por: Scholten, Marlieke, et al.
Publicado: (2017)

Reversing Parkinson Disease Model with in situ Converted Nigral Neurons
por: Qian, Hao, et al.
Publicado: (2020)

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson’s disease
por: Pflug, Christina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_22d1nqis0t6kueim3jid3is74k